Ó³»­´«Ã½

Search engines have increasingly become advertising agents for big companies. Thus, search results have inherent biases in what gets prioritized for whom. In this conversation, and Anne Carpenter explored questions like: what does it mean when large companies have enormous influence on public knowledge? What are the consequences of these tensions between industry and public good? What is the interplay between big tech and biomedical science? How do we make sure biomedical research, particularly those relying on machine learning methods, is equitably beneficial to all? As technologies increasingly drive major decision-making, how can we make sure to enact civil and human rights protections to build a fairer and more just data-driven society?

About the Equity in Biomedicine Seminar Series (EBM)
This video is part of the Equity in Biomedicine Seminar Series (EBM), an institute-wide interactive meeting that focuses on critical issues related to equity and representation in biomedical research, especially as it applies to genomics research and precision medicine. Speakers dive into the equal or unequal social implications of their work: Who is affected? How are they affected? Why? The overall goal of this series is to foster discussions about equity and inspire Ó³»­´«Ã½ scientists and trainees to reflect on the social impact of their own research.

The EBM series is sponsored by the IDEA Office; each event in the series is presented by one or more Ó³»­´«Ã½ scientific groups in collaboration with  and the organizing committee. For more information about the EBM series or to nominate a future seminar speaker, contact Mireille Kamariza.